{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:51:21Z","timestamp":1792734681949,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cct.2020.106156","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T17:41:36Z","timestamp":1600882896000},"page":"106156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study"],"prefix":"10.1016","volume":"98","author":[{"given":"E. Jennifer","family":"Edelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah H.","family":"Cornman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rebick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Yager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Morford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas B.","family":"Muvvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cct.2020.106156_bb0005","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s10461-016-1584-6","article-title":"Prevalence and predictors of substance use disorders among HIV care enrollees in the United States","volume":"21","author":"Hartzler","year":"2017","journal-title":"AIDS Behav."},{"issue":"6","key":"10.1016\/j.cct.2020.106156_bb0010","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2214-109X(17)30170-5","article-title":"Tobacco use among people living with HIV: analysis of data from demographic and health surveys from 28 low-income and middle-income countries","volume":"5","author":"Mdege","year":"2017","journal-title":"Lancet Glob. Health"},{"issue":"10","key":"10.1016\/j.cct.2020.106156_bb0015","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/acer.13204","article-title":"Alcohol use and human immunodeficiency virus (HIV) infection: current knowledge, implications, and future directions","volume":"40","author":"Williams","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.cct.2020.106156_bb0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","article-title":"Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America","volume":"29","author":"Helleberg","year":"2015","journal-title":"AIDS."},{"issue":"2","key":"10.1016\/j.cct.2020.106156_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAI.0b013e31826741aa","article-title":"Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care","volume":"61","author":"Korthuis","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.cct.2020.106156_bb0030","series-title":"Opioid overdose deaths among persons with HIV infection, United States, 2011-2015, Abstract #147. Paper Presented at: CROI2019","author":"Bosh","year":"2020"},{"key":"10.1016\/j.cct.2020.106156_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2014.03.006","article-title":"The impact of buprenorphine\/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients","volume":"139","author":"Edelman","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.cct.2020.106156_bb0040","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/S2352-3018(18)30002-X","article-title":"Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 inter-ACTIV): a randomised controlled phase 3 clinical trial","volume":"5","author":"Mercie","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cct.2020.106156_bb0045","article-title":"Interventions for tobacco use cessation in people living with HIV and AIDS","volume":"6","author":"Pool","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.cct.2020.106156_bb0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1530-0277.2011.01601.x","article-title":"Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone","volume":"36","author":"Tetrault","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10461-018-2241-z","article-title":"Efficacy of extended-release naltrexone on HIV-related and drinking outcomes among HIV-positive patients: a randomized-controlled trial","volume":"23","author":"Edelman","year":"2018","journal-title":"AIDS Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2020.106156_bb0060","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study","volume":"56","author":"Altice","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2020.106156_bb0065","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/QAI.0b013e3182097537","article-title":"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine\/naloxone","volume":"56","author":"Fiellin","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"5","key":"10.1016\/j.cct.2020.106156_bb0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/QAD.0000000000002125","article-title":"Integration of care for HIV and opioid use disorder: a systematic review of interventions in clinical and community-based settings","volume":"33","author":"Oldfield","year":"2018","journal-title":"AIDS."},{"key":"10.1016\/j.cct.2020.106156_bb0075","series-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","author":"Department of Health and Human Services","year":"2019"},{"key":"10.1016\/j.cct.2020.106156_bb0080","series-title":"SAMHSA-HRSA","article-title":"A review and proposed standard framework for levels of integrated healthcare","author":"BWRP","year":"2013"},{"key":"10.1016\/j.cct.2020.106156_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsat.2015.07.007","article-title":"Engagement and substance dependence in a primary care-based addiction treatment program for people infected with HIV and people at high-risk for HIV infection","volume":"59","author":"Walley","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2020.106156_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pmedr.2017.02.012","article-title":"Disparities in receipt of 5As for smoking cessation in diverse primary care and HIV clinics","volume":"6","author":"Vijayaraghavan","year":"2017","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.cct.2020.106156_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jsat.2019.11.002","article-title":"Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV","volume":"109","author":"Oldfield","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"issue":"2","key":"10.1016\/j.cct.2020.106156_bb0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pcad.2020.01.003","article-title":"Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV","volume":"63","author":"Shahrir","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cct.2020.106156_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.cct.2020.106156_bb0110","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/09540121.2015.1050983","article-title":"Patient and provider priorities for self-reported domains of HIV clinical care","volume":"27","author":"Fredericksen","year":"2015","journal-title":"AIDS Care"},{"key":"10.1016\/j.cct.2020.106156_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2016.01.015","article-title":"HIV primary care providers--screening, knowledge, attitudes and behaviors related to alcohol interventions","volume":"161","author":"Chander","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2020.106156_bb0120","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/QAI.0b013e31820a9a82","article-title":"Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings","volume":"56","author":"Lum","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.cct.2020.106156_bb0125","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s11606-018-4581-9","article-title":"Impact of practice facilitation in primary care on chronic disease care processes and outcomes: a systematic review","volume":"33","author":"Wang","year":"2018","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1370\/afm.1312","article-title":"Systematic review and meta-analysis of practice facilitation within primary care settings","volume":"10","author":"Baskerville","year":"2012","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.cct.2020.106156_bb0135","author":"AHRQ"},{"key":"10.1016\/j.cct.2020.106156_bb0140","author":"AHRQ"},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","article-title":"Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (project ED HEALTH)","volume":"14","author":"D\u2019Onofrio","year":"2019","journal-title":"Implement. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.cct.2020.106156_bb0150","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s11606-006-0267-9","article-title":"The role of formative evaluation in implementation research and the QUERI experience","volume":"21","author":"Stetler","year":"2006","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2020.106156_bb0155","doi-asserted-by":"crossref","first-page":"101012","DOI":"10.1016\/j.pmedr.2019.101012","article-title":"Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): results from a survey of primary care providers","volume":"17","author":"Edelman","year":"2020","journal-title":"Prev. Med. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2020.106156_bb0160","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","article-title":"Integration of buprenorphine\/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative","volume":"56","author":"Weiss","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"9","key":"10.1016\/j.cct.2020.106156_bb0165","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jclinepi.2010.12.003","article-title":"Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation","volume":"64","author":"Mdege","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.cct.2020.106156_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med. Care"},{"key":"10.1016\/j.cct.2020.106156_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-5908-6-99","article-title":"A guide for applying a revised version of the PARIHS framework for implementation","volume":"6","author":"Stetler","year":"2011","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2020.106156_bb0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1748-5908-5-82","article-title":"A critical synthesis of literature on the promoting action on research implementation in health services (PARIHS) framework","volume":"5","author":"Helfrich","year":"2010","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2020.106156_bb0185","series-title":"Integration of Infectious Diseases and Substance Abuse Intervention Services for Individuals Living with HIV (R01) (RFA-DA-15-013)","author":"National Institute on Health","year":"2015"},{"key":"10.1016\/j.cct.2020.106156_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13063-015-0839-2","article-title":"Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014","volume":"16","author":"Beard","year":"2015","journal-title":"Trials."},{"key":"10.1016\/j.cct.2020.106156_bb0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2288-6-54","article-title":"The stepped wedge trial design: a systematic review","volume":"6","author":"Brown","year":"2006","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.cct.2020.106156_bb0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","article-title":"Design and analysis of stepped wedge cluster randomized trials","volume":"28","author":"Hussey","year":"2007","journal-title":"Contemp. Clin. Trials"},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13722-018-0127-z","article-title":"Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities","volume":"13","author":"Hagedorn","year":"2018","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s43058-020-00062-0","article-title":"Practice facilitation to implement alcohol-related care in veterans health administration liver clinics: a study protocol","volume":"1","author":"Frost","year":"2020","journal-title":"Implement. Sci. Commun."},{"issue":"3","key":"10.1016\/j.cct.2020.106156_bb0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within veterans health administration facilities","volume":"41","author":"Gordon","year":"2020","journal-title":"Subst. Abus."},{"key":"10.1016\/j.cct.2020.106156_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsat.2017.09.002","article-title":"Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US veterans health administration","volume":"82","author":"Harris","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13012-018-0838-2","article-title":"Testing implementation facilitation of a primary care-based collaborative care clinical program using a hybrid type III interrupted time series design: a study protocol","volume":"13","author":"Midboe","year":"2018","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2020.106156_bb0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addbeh.2018.03.009","article-title":"Mixed methods formative evaluation of a collaborative care program to decrease risky opioid prescribing and increase non-pharmacologic approaches to pain management","volume":"86","author":"Becker","year":"2018","journal-title":"Addict. Behav."},{"issue":"9","key":"10.1016\/j.cct.2020.106156_bb0235","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s11606-010-1377-y","article-title":"The physician clinical support system-buprenorphine (PCSS-B): a novel project to expand\/improve buprenorphine treatment","volume":"25","author":"Egan","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2020.106156_bb0240","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1748-5908-4-38","article-title":"Organizational readiness to change assessment (ORCA): development of an instrument based on the promoting action on research in health services (PARIHS) framework","volume":"4","author":"Helfrich","year":"2009","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2020.106156_bb0245","author":"Center for Interdisciplinary Research on AIDS"},{"issue":"6","key":"10.1016\/j.cct.2020.106156_bb0250","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/hiv.12219","article-title":"Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system","volume":"16","author":"Edelman","year":"2015","journal-title":"HIV Med."},{"issue":"11","key":"10.1016\/j.cct.2020.106156_bb0255","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/apc.2016.0188","article-title":"Reengagement in care after a gap in HIV care among a population of privately insured persons with HIV in the United States","volume":"30","author":"Byrd","year":"2016","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.cct.2020.106156_bb0260","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10461-016-1612-6","article-title":"Primary care Physicians\u2019 willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs","volume":"21","author":"Edelman","year":"2017","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0265","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-016-3903-z","article-title":"A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians","volume":"32","author":"Blackstock","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2020.106156_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1748-5908-5-46","article-title":"The relationship between baseline organizational readiness to change assessment subscale scores and implementation of hepatitis prevention services in substance use disorders treatment clinics: a case study","volume":"5","author":"Hagedorn","year":"2010","journal-title":"Implement. Sci."},{"key":"10.1016\/j.cct.2020.106156_bb0275","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1748-5908-8-120","article-title":"Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation","volume":"8","author":"Owen","year":"2013","journal-title":"Implement. Sci."},{"issue":"5","key":"10.1016\/j.cct.2020.106156_bb0280","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cct.2020.106156_bb0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B0-12-369398-5\/00562-4","article-title":"Rapid assessment process","author":"Beebe","year":"2005","journal-title":"Encyclop. Social Measure."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13012-019-0853-y","article-title":"Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the veterans health administration","volume":"14","author":"Gale","year":"2019","journal-title":"Implement. Sci."},{"issue":"9","key":"10.1016\/j.cct.2020.106156_bb0295","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual. Health Res."},{"issue":"10","key":"10.1016\/j.cct.2020.106156_bb0300","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/CIRCULATIONAHA.107.742775","article-title":"Qualitative and mixed methods provide unique contributions to outcomes research","volume":"119","author":"Curry","year":"2009","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.cct.2020.106156_bb0305","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000002140","article-title":"Veterans aging cohort S, the antiretroviral therapy cohort C. albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals","volume":"33","author":"Tate","year":"2019","journal-title":"AIDS."},{"key":"10.1016\/j.cct.2020.106156_bb0310","series-title":"Healthcare Cost and Utilization Project","author":"Agency for Healthcare Research and Quality","year":"2019"},{"key":"10.1016\/j.cct.2020.106156_bb0315","series-title":"VA\/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF SUBSTANCE USE DISORDERS","author":"Veterans Health Administration","year":"2020"},{"key":"10.1016\/j.cct.2020.106156_bb0320","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.cct.2020.106156_bb0325","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2016.01.017","article-title":"Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men","volume":"161","author":"Justice","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2020.106156_bb0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugalcdep.2018.04.022","article-title":"Changes in alcohol use associated with changes in HIV disease severity over time: a national longitudinal study in the veterans aging cohort","volume":"189","author":"Williams","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2020.106156_bb0335","series-title":"Using Implementation Facilitation to Improve Care in the Veterans Health Administration (Version 2).","author":"Ritchie","year":"2017"},{"issue":"4","key":"10.1016\/j.cct.2020.106156_bb0340","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s11606-019-05537-y","article-title":"Time and organizational cost for facilitating implementation of primary care mental health integration","volume":"35","author":"Ritchie","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"7","key":"10.1016\/j.cct.2020.106156_bb0345","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jclinepi.2013.01.009","article-title":"Stepped wedge designs could reduce the required sample size in cluster randomized trials","volume":"66","author":"Woertman","year":"2013","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.cct.2020.106156_bb0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/QAI.0b013e318273762f","article-title":"Measuring retention in HIV care: the elusive gold standard","volume":"61","author":"Mugavero","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.cct.2020.106156_bb0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","article-title":"A comparison of methods to test mediation and other intervening variable effects","volume":"7","author":"MacKinnon","year":"2002","journal-title":"Psychol. Methods"},{"issue":"4","key":"10.1016\/j.cct.2020.106156_bb0360","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0193-953X(03)00073-X","article-title":"Evidence-based practices for substance use disorders","volume":"26","author":"McGovern","year":"2003","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.cct.2020.106156_bb0365","series-title":"National Resource Center for Academic Detailing (NaRCAD)","year":"2020"},{"key":"10.1016\/j.cct.2020.106156_bb0370","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsat.2018.11.007","article-title":"No more falling through the cracks: a qualitative study to inform measurement of integration of care of HIV and opioid use disorder","volume":"97","author":"Oldfield","year":"2019","journal-title":"J. Subst. Abus. Treat."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420302342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420302342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:50:34Z","timestamp":1761555034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714420302342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":74,"alternative-id":["S1551714420302342"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2020.106156","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): Rationale and design for a hybrid type 3 effectiveness-implementation study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2020.106156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106156"}}